Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Stock Holdings Trimmed by MetLife Investment Management LLC

MetLife Investment Management LLC lessened its position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 1.8% during the third quarter, Holdings Channel reports. The institutional investor owned 47,964 shares of the company’s stock after selling 857 shares during the quarter. MetLife Investment Management LLC’s holdings in Acadia Healthcare were worth $3,041,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently modified their holdings of the company. Glenmede Trust Co. NA raised its stake in shares of Acadia Healthcare by 40.2% in the 3rd quarter. Glenmede Trust Co. NA now owns 5,327 shares of the company’s stock worth $338,000 after buying an additional 1,528 shares in the last quarter. BNP Paribas Financial Markets raised its stake in shares of Acadia Healthcare by 1,601.3% in the 3rd quarter. BNP Paribas Financial Markets now owns 281,220 shares of the company’s stock worth $17,832,000 after buying an additional 264,690 shares in the last quarter. Bank of Montreal Can raised its stake in shares of Acadia Healthcare by 2,456.1% in the 3rd quarter. Bank of Montreal Can now owns 324,569 shares of the company’s stock worth $20,539,000 after buying an additional 311,871 shares in the last quarter. Dynamic Technology Lab Private Ltd bought a new stake in shares of Acadia Healthcare in the 3rd quarter worth $458,000. Finally, Cerity Partners LLC raised its position in shares of Acadia Healthcare by 43.7% during the third quarter. Cerity Partners LLC now owns 32,922 shares of the company’s stock worth $2,088,000 after purchasing an additional 10,019 shares during the period.

Acadia Healthcare Stock Performance

Shares of ACHC stock opened at $42.25 on Wednesday. The stock’s fifty day simple moving average is $49.78 and its 200-day simple moving average is $63.31. The company has a current ratio of 1.07, a quick ratio of 1.07 and a debt-to-equity ratio of 0.60. Acadia Healthcare Company, Inc. has a 1-year low of $36.50 and a 1-year high of $87.77. The company has a market capitalization of $3.92 billion, a price-to-earnings ratio of 13.85, a P/E/G ratio of 1.88 and a beta of 1.30.

Acadia Healthcare (NASDAQ:ACHC) last issued its earnings results on Wednesday, October 30th. The company reported $0.91 EPS for the quarter, beating analysts’ consensus estimates of $0.90 by $0.01. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. The firm had revenue of $815.60 million for the quarter, compared to the consensus estimate of $819.42 million. During the same quarter in the previous year, the company posted $0.91 earnings per share. The business’s quarterly revenue was up 8.7% compared to the same quarter last year. On average, sell-side analysts predict that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

ACHC has been the topic of a number of recent analyst reports. StockNews.com lowered Acadia Healthcare from a “hold” rating to a “sell” rating in a research report on Friday, November 22nd. KeyCorp initiated coverage on Acadia Healthcare in a research report on Friday, October 11th. They set a “sector weight” rating on the stock. Barclays cut their target price on Acadia Healthcare from $76.00 to $43.00 and set an “overweight” rating on the stock in a research report on Friday, November 22nd. Royal Bank of Canada cut their target price on Acadia Healthcare from $94.00 to $64.00 and set an “outperform” rating on the stock in a research report on Monday, November 18th. Finally, Cantor Fitzgerald reaffirmed a “neutral” rating and set a $90.00 target price on shares of Acadia Healthcare in a research report on Tuesday, October 1st. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and six have issued a buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $79.67.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.